Category Archive: Finance

E
                                                
                        Lithium Battery Demand – Fact Or Fiction?

E Lithium Battery Demand – Fact Or Fiction?

What is the growth potential of electric cars and battery storage? The answer seems to depend on your political view.Wall Street, however, doesn’t care about ideology. Money flows to areas of opportunity and investors are increasingly optimistic on electric battery power. The evidence: The Global X Lithium & Battery ETF (LIT) has had an inflow […]
Merck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong

Merck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong

Merck & Co., Inc. (MRK – Free Report) reported third-quarter 2017 adjusted earnings of $1.11 per share, which beat the Zacks Consensus Estimate of $1.03 by 7.8%. Earnings rose 3.7% year over year. Among other items, adjusted earnings exclude a charge related to its new oncology collaboration with Britain’s AstraZeneca (AZN – Free Report) . Revenues for the quarter declined […]
Proof That A Major Bull Market Is Coming

Proof That A Major Bull Market Is Coming

There is life in the junior mining space. I don’t mean that shares are rocketing higher (yet). What I mean is that there is money coming back in. Companies can raise long-awaited and much-needed cash. What I see right now, as I write this from the Mining & Investment Latin America Summit in Lima, Peru, […]
Hyperinflation Chronicles: Einstein’s Scribble, Newman’s Watch, And Dot-Blockchain

Hyperinflation Chronicles: Einstein’s Scribble, Newman’s Watch, And Dot-Blockchain

When governments create insane amounts of money, the recipients of that money tend to behave accordingly. Consider: Einstein scribbled his theory of happiness in place of a tip. It just sold for more than $1 million. (Washington Post) – He is known as one of the great minds in 20th-century science. But this week, Albert […]
Celgene: Growth At A Reasonable Price Even On Revised Guidance

Celgene: Growth At A Reasonable Price Even On Revised Guidance

This article is an update to my original article on Celgene published on June 22, 2017.Celgene reported their financial results yesterday October 26, 2017, and although the quarter was good, lowered guidance crushed the stock price. In my opinion, some of the sag in price was justified, but for the most part an overreaction. Celgene is still […]
Is The CVS Health/Aetna Proposal Really Just About Amazon?

Is The CVS Health/Aetna Proposal Really Just About Amazon?

Financial journalists seem to have a pretty simple playbook these days. Most any retail-related corporate development is a direct result of Amazon (AMZN). Plain and simple. No questions asked. Last night it was reported that CVS Health (CVS) has made a bid for health insurer Aetna (AET). Immediately the media closed the book on the strategic rationale for the […]
Why Bitcoin Should Be In Your Retirement Portfolio

Why Bitcoin Should Be In Your Retirement Portfolio

People think you should buy bitcoin because the price might go up. But the real reason you should own bitcoin – especially in your retirement portfolio – is that it’s a bet on a monetary revolution. Crypto assets are all about cutting out the banks, middlemen, financiers and academics who control our current monetary system. The monetary […]
Tech Stocks Outperform Most Since 2009, Add Massive $180 Billion Market Cap

Tech Stocks Outperform Most Since 2009, Add Massive $180 Billion Market Cap

The Nasdaq is dramatically outperforming the rest of the major US equity indices today… In fact this this is the biggest Nasdaq outperformance of the S&P since May 2009… “We saw some weakness in the stocks of tech megacaps recently, not so much because of a concern about mediocre earnings but rather because a concern […]
AbbVie (ABBV) Q3 Earnings Top, Revenues In Line, View Up

AbbVie (ABBV) Q3 Earnings Top, Revenues In Line, View Up

AbbVie Inc. (ABBV – Free Report) reported mixed results in the third quarter of 2017. The company surpassed earnings estimates, while posted in-line revenues during the period. Importantly, the company raised its long-term sales expectations of its blockbuster rheumatoid arthritis drug Humira, despite rising competition in the market. In response, shares nudged up almost 2% in pre-market trading. […]
CVS Said To Bid Over $66B To Buy Aetna As Amazon Threat Looms

CVS Said To Bid Over $66B To Buy Aetna As Amazon Threat Looms

Shares of Aetna (AET) are in focus in morning trading after CVS Health (CVS) reportedly made a more than $66B offer for the insurer, according to The Wall Street Journal. The report said the two sides have been in discussions about a deal for at least two months. The Aetna/CVS rumors are heating up amid […]